10 results found.

Insomnia, or Suicidal Ideation Clinical Trial using Behavioral Insomnia Treatment

Stanford University - Recruiting 18 years or older.
- A Sleep-Oriented Intervention for Suicidal Behaviors.
Behavioral Insomnia Treatment

Bipolar Disorder, Major Depressive Episode, or Suicidal Ideation Clinical Trial using Ketamine; Midazolam

New York State Psychiatric Institute - Recruiting 18 years to 65 years.
- Ketamine vs. Midazolam in Bipolar Depression.
Ketamine; Midazolam

Suicidal Ideation Clinical Trial using Group Intervention; Treatment as usual

Children's Hospital of Eastern Ontario - Recruiting 13 years to 17 years.
- Brief Group Intervention for Adolescents With Mild to Moderate Suicidal Ideation and Their Caregivers: Preliminary Investigation for a Novel Treatment Approach.
Group Intervention; Treatment as usual

Insomnia, Depression, or Suicidal Ideation Clinical Trial using Zolpidem-CR; Placebo

Georgia Regents University - Recruiting 18 years to 65 years.
- Reducing Suicidal Ideation Through Insomnia Treatment.
Zolpidem-CR; Placebo

Depression, or Suicidal Ideation Clinical Trial using Ketamine; placebo

University of Alabama at Birmingham - Recruiting 19 years or older.
- Treatment of Suicidal Ideation With Intravenous Ketamine Infusion.
Ketamine; placebo

Suicide, or Suicidal Ideation Clinical Trial using Treatment As Usual (TAU); Crisis Response Plan (CRP); Enhanced Crisis Response Plan (E-CRP)

University of Utah - Recruiting 18 years to 65 years.
- Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations.
Treatment As Usual (TAU); Crisis Response Plan (CRP); Enhanced Crisis Response Plan (E-CRP)

Suicidal Ideation, or Treatment Engagement Clinical Trial using Motivational Interviewing to Address Suicidal Ideation (MI-SI)

Department of Veterans Affairs - Recruiting 18 years or older.
- Motivational Interviewing to Prevent Suicide in High Risk Veterans.
Motivational Interviewing to Address Suicidal Ideation (MI-SI)

Major Depressive Disorder Clinical Trial using CERC-301; Placebo

Cerecor Inc - Recruiting 18 years to 70 years.
- A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment.
CERC-301; Placebo

PTSD, or Suicidal Ideation Clinical Trial

VA Eastern Colorado Health Care System - Recruiting 18 years to 65 years.
- Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder.

Depression Clinical Trial

Hallym University Medical Center - Recruiting 13 years to 18 years.
- Suicidal Ideation and Behavior in Korean Adolescents With Depression.